Neurana Pharmaceuticals Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Out of Business

Neurana Pharmaceuticals General Information

Description

Operator of a specialty pharmaceutical agency intended to treat neuromuscular conditions. The company's agency offers a novel skeletal muscle relaxant for the treatment of acute, painful muscle spasms and spasticity, enabling patients to avail of fast relief without sedation.

Contact Information

Website
www.neuranapharma.com
Formerly Known As
Katama Pharmaceuticals
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 4370 La Jolla Village Drive
  • Suite 860
  • San Diego, CA 92122
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • 4370 La Jolla Village Drive
  • Suite 860
  • San Diego, CA 92122
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurana Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 18-Oct-2022 Completed Out of Business
4. Secondary Transaction - Private Completed Generating Revenue
3. Later Stage VC (Series A) 16-Nov-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 03-May-2018 $60M $61M Completed Generating Revenue
1. Early Stage VC 10-Mar-2017 $1.05M $1.05M Completed Generating Revenue
To view Neurana Pharmaceuticals’s complete valuation and funding history, request access »

Neurana Pharmaceuticals Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Neurana Pharmaceuticals’s complete cap table history, request access »

Neurana Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a specialty pharmaceutical agency intended to treat neuromuscular conditions. The company's agency offers a
Drug Discovery
San Diego, CA
14 As of 2021

Bresso, Italy
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neurana Pharmaceuticals Competitors (58)

One of Neurana Pharmaceuticals’s 58 competitors is The Zambon Group, a Private Debt Financed company based in Bresso, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
The Zambon Group Private Debt Financed Bresso, Italy
Foventa Therapeutics Venture Capital-Backed Cambridge, United Kingdom
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India
Pfizer (Vienna) Corporation Vienna, Austria
You’re viewing 5 of 58 competitors. Get the full list »

Neurana Pharmaceuticals Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Neurana Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021146425-A1 Methods of treating acute muscle spasms Inactive 14-Jan-2020
JP-2021503499-A How to administer tolperisone Pending 17-Nov-2017
EP-3709989-A1 Methods of administering tolperisone Inactive 17-Nov-2017
EP-3709989-A4 Methods of administering tolperisone Inactive 17-Nov-2017
US-20200390754-A1 Methods of administering tolperisone Inactive 17-Nov-2017 A61K31/4453
To view Neurana Pharmaceuticals’s complete patent history, request access »

Neurana Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Neurana Pharmaceuticals FAQs

  • When was Neurana Pharmaceuticals founded?

    Neurana Pharmaceuticals was founded in 2013.

  • Where is Neurana Pharmaceuticals headquartered?

    Neurana Pharmaceuticals is headquartered in San Diego, CA.

  • What is the size of Neurana Pharmaceuticals?

    Neurana Pharmaceuticals has 14 total employees.

  • What industry is Neurana Pharmaceuticals in?

    Neurana Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Neurana Pharmaceuticals a private or public company?

    Neurana Pharmaceuticals is a Private company.

  • What is Neurana Pharmaceuticals’s current revenue?

    The current revenue for Neurana Pharmaceuticals is .

  • How much funding has Neurana Pharmaceuticals raised over time?

    Neurana Pharmaceuticals has raised $71.1M.

  • Who are Neurana Pharmaceuticals’s competitors?

    The Zambon Group, Foventa Therapeutics, BioMarin Pharmaceutical, Intas Pharmaceuticals, and Pfizer (Vienna) are some of the 58 competitors of Neurana Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process